Aetna Dupilumab (Dupixent) prior authorization requirements (2026)
What Aetna generally requires to approve Dupilumab (Dupixent) (CPT J0517), for Commercial (specialty pharmacy benefit; J0517 medical benefit) plans. Yes. Aetna generally requires prior authorization for Dupilumab (Dupixent) (CPT J0517).
Medical-necessity criteria Aetna generally applies
Prior authorization required (specialty pharmacy benefit; HCPCS J0517 under the medical benefit; prescribed by/with a dermatologist or allergist/immunologist). ATOPIC DERMATITIS: age 6 months or older; affected body surface area at least 10%, OR involvement of crucial areas (hands, feet, face, neck, scalp, genitals/groin, intertriginous areas); AND an inadequate response within the past 180 days to either a high/super-high-potency topical corticosteroid OR a topical calcineurin inhibitor (or both are not advisable). A 4-month authorization may also be granted to patients who previously received a biologic or targeted synthetic drug. Initial approval 4 months; continuation 12 months with a positive clinical response.
Diagnoses that commonly support medical necessity
ICD-10-CM diagnoses frequently associated with medical necessity for Dupilumab (Dupixent). Confirm the covered diagnosis list against the current Aetna policy.
Commonly required documentation
- Diagnosis and severity (BSA or crucial-area involvement)
- documented topical trial within 180 days
- specialist prescriber.
How to submit
- Method: Aetna specialty pharmacy precertification
- Portal: Availity
Source
Source: Aetna specialty bulletin Atopic Dermatitis Dupixent 1743-A P2024a. Requires one topical-class failure. Last verified 2026-06-17.
Frequently asked questions
Does Aetna require prior authorization for Dupilumab (Dupixent)?
Yes. Aetna generally requires prior authorization for Dupilumab (Dupixent) (CPT J0517).
What does Aetna require to approve Dupilumab (Dupixent)?
Prior authorization required (specialty pharmacy benefit; HCPCS J0517 under the medical benefit; prescribed by/with a dermatologist or allergist/immunologist). ATOPIC DERMATITIS: age 6 months or older; affected body surface area at least 10%, OR involvement of crucial areas (hands, feet, face, neck, scalp, genitals/groin, intertriginous areas); AND an inadequate response within the past 180 days t… Always confirm against the current Aetna policy.
How long does a Aetna prior authorization take?
Turnaround varies by plan and submission method. Check the Aetna portal for current timeframes.
Submitting Dupilumab (Dupixent) to Aetna?
Praxigen checks your clinical note against these criteria before you submit and drafts a policy-cited appeal if it is denied. You review and submit; nothing is sent automatically.